Enjoy complimentary customisation on priority with our Enterprise License!
The montelukast sodium market share is expected to increase by USD 1.88 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.1%.
This montelukast sodium market research report extensively covers market segmentation by type (tablets, chewable tablets, and oral solutions) and geography (North America, Europe, APAC, and Rest of World (ROW)). This high-temperature filters market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches.
Download the Free Report Sample to Unlock the Montelukast Sodium Market Size for the Forecast Period and Other Important Statistics
The montelukast sodium market report also offers information on several market vendors, including Apotex Inc., Aurobindo Pharma Ltd., Bio Techne Corp., Cayman Chemical Co., Cipla Ltd., Glenmark Pharmaceuticals Ltd., Hetero Healthcare Ltd., Hikma Pharmaceuticals Plc, Jubilant Pharmova Ltd., Krosyl Pharmaceuticals Pvt. Ltd. , Merck and Co. Inc., Morepen Laboratories Ltd., Novartis AG, Simson Pharma Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Unichem Laboratories Ltd., Unimark Remedies Ltd., and Viatris Inc. among others.
The increasing demand for asthma medications is notably driving the montelukast sodium market growth, although factors such as challenges associated with screening and diagnosis may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the montelukast sodium industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Montelukast Sodium Market Driver
Key Montelukast Sodium Market Trend
Key Montelukast Sodium Market Challenge
This montelukast sodium market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global montelukast sodium market as a part of the global specialty chemicals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the montelukast sodium market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the montelukast sodium market encompasses successful business strategies deployed by the key vendors. The montelukast sodium market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The montelukast sodium market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the montelukast sodium market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
34% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for montelukast sodium in North America. However, market growth in this region will be slower than the growth of the market in other regions.
The existence of prominent vendors, the high prevalence of asthma and other respiratory disorders, and the developed healthcare infrastructure will facilitate the montelukast sodium market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The montelukast sodium market in North America witnessed a temporary decline in 2020, owing to the COVID-19 outbreak. A decrease in pollution due to the associated lockdown and the increased use of masks decreased the prevalence of allergic rhinitis in 2020, which adversely affected the market in North America. However, by January 2021, following the widespread COVID-19 vaccination drives, lockdown restrictions in various countries were somewhat relaxed, which led to the resumption of business activities. Thus, this is expected to increase the demand for montelukast sodium in North America during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The montelukast sodium market share growth by the tablets segment will be significant during the forecast period. Most tablets contain additives that hold the pill together and improve the taste, texture, or appearance in addition to the active chemicals. The demand for montelukast sodium tablets grows as the number of patients increases. Therefore, the market for the tablet segment will grow in the forecast years.
This report provides an accurate prediction of the contribution of all the segments to the growth of the montelukast sodium market size and actionable market insights on post COVID-19 impact on each segment.
Dental Cleansing Tablet market - The market share is expected to increase to USD 385.48 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.92%.
Oral Hygiene market - The market share is expected to increase to USD 12.16 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.75%.
Montelukast Sodium Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.1% |
Market growth 2022-2026 |
$ 1.88 billion |
Market structure |
Fragmented |
YoY growth (%) |
5.1 |
Regional analysis |
North America, Europe, APAC, and Rest of World (ROW) |
Performing market contribution |
North America at 34% |
Key consumer countries |
US, Canada, China, Germany, and UK |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Apotex Inc., Aurobindo Pharma Ltd., Bio Techne Corp., Cayman Chemical Co., Cipla Ltd., Glenmark Pharmaceuticals Ltd., Hetero Healthcare Ltd., Hikma Pharmaceuticals Plc, Jubilant Pharmova Ltd., Krosyl Pharmaceuticals Pvt. Ltd. , Merck and Co. Inc., Morepen Laboratories Ltd., Novartis AG, Simson Pharma Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Unichem Laboratories Ltd., Unimark Remedies Ltd., and Viatris Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.